Who we are
We are the largest privately owned and independent company dedicated to the research and development of life saving or life altering therapies from human plasma or human cell lines for persons with rare diseases.
/f/54881/1091x726/64cad4c78b/sweden2.jpg)
About us
Our five values -Ownership, Integrity, Leadership, Sustainability and Entrepreneurship- guide our patient-oriented corporate culture. We aspire to embody these values in everything we do.
Diseases & therapies
We develop life-saving therapies in three therapy areas: Hematology, Immunotherapy and Critical care.
Research & development
We conduct pre-clinical and clinical research to identify and develop innovative new treatments and ensure their safe use.
Our locations
We serve people with rare diseases in 118 countries around the world. We live and work in 31 countries directly, conduct our R&D in 7 locations and operate 6 state of the art manufacturing sites in Europe and North America.